Fimab SA
Fimab reported total assets of €3.08m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Apr 2026).
The score of Fimab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -8 % Total assets -21 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Fimab's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 30 Apr 2026
- Year ended 30 Sep 2024filed on 28 Apr 2025
- Year ended 30 Sep 2023filed on 30 Apr 2024
- Year ended 30 Sep 2022filed on 23 May 2023
- Year ended 30 Sep 2021filed on 25 May 2022
Fimab's financial analysis
- Solvency85.1%sector median: 46.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Fimab
Fimab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0459.189.585
- VAT number
- BE0459189585
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 12 Nov 1996
- Registered office
- 9406 Ninove
- Latest accounts
- 2025 · filed on 30 Apr 2026
- Activity
- Rental and operating of own or leased residential real estate, except social housing (NACE 68201)
Fimab (SA) has been based in Ninove since 1996, active in: rental and operating of own or leased residential real estate, except social housing. For 2025, it reports a net loss of 10,418 € and equity of €2.62m; its revenue is not published. Its solvency stands at 85.1%, above the median of its sector (46.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Fimab
Companies in the same business, of comparable size and area, outside its group.
- Four Stars Ostend Rental and operating of own or leased real estate Ostend · balance sheet €3.02m
- Magreco - Invest Rental and operating of own or leased real estate Sint-Niklaas · balance sheet €3.32m
- Frateur Immo Rental and operating of own or leased real estate Boom · balance sheet €3.65m
- Waterloo Rental and operating of own or leased real estate Brussels · balance sheet €3.07m
- Lacre Rental and operating of own or leased real estate Uccle · balance sheet €3.10m
- Alminlease Rental and operating of own or leased real estate Kontich · balance sheet €3.10m
- Riorim Rental and operating of own or leased real estate Ixelles · balance sheet €3.04m
- Immobiliere Saint Martin Rental and operating of own or leased real estate Walhain · balance sheet €3.02m
Frequently asked questions about Fimab
What is the revenue of Fimab?
Fimab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Fimab?
In Belgium, the VAT number is the company number prefixed with BE: BE0459189585 for Fimab, if the company is VAT-registered. Its company number (CBE) is 0459.189.585.
Where is the registered office of Fimab?
According to the CBE register, the registered office of Fimab is in 9406 Ninove.
What is the equity of Fimab?
At the close of the 2025 financial year, the equity of Fimab amounts to 2,620,060 €, a solvency of 85.1% of total assets.
Who manages Fimab?
The register lists 7 active mandates at Fimab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Fimab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →